ImpediMed Limited Profit Margin

The latest profit margin for IPD.AX is -176.11% as of June 2026. That compares with -186.08% in the prior-year period — up 5.4% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside ImpediMed Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, IPD.AX's profit margin moved from -186.08% to -176.11% — a 5.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ImpediMed Limited's valuation or profitability profile.

Against its sector companies, IPD.AX currently prints -176.11% for profit margin, while the sector average sits near 13.2%. That is roughly 1434.3% below the sector mean. Large gaps often invite a closer look at ImpediMed Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively ImpediMed Limited converts resources into returns. At -176.11%, IPD.AX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -186.08% in the prior-year period — up 5.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IPD.AX's profit margin (-176.11%), review year-over-year change from -186.08%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.